HomeCompareBASV vs JNJ

BASV vs JNJ: Dividend Comparison 2026

BASV yields 0.43% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BASV wins by $256.00 in total portfolio value
10 years
BASV
BASV
● Live price
0.43%
Share price
$26.48
Annual div
$0.11
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$44.51
Full BASV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BASV vs JNJ

📍 BASV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBASVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BASV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BASV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BASV
Annual income on $10K today (after 15% tax)
$36.79/yr
After 10yr DRIP, annual income (after tax)
$37.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $665.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BASV + JNJ for your $10,000?

BASV: 50%JNJ: 50%
100% JNJ50/50100% BASV
Portfolio after 10yr
$20.1K
Annual income
$436.15/yr
Blended yield
2.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BASV
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BASV buys
0
JNJ buys
0
No recent congressional trades found for BASV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBASVJNJ
Forward yield0.43%3.36%
Annual dividend / share$0.11$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.3K$20.0K
Annual income after 10y$44.51$827.78
Total dividends collected$439.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BASV vs JNJ ($10,000, DRIP)

YearBASV PortfolioBASV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,743$43.28$10,676$355.77+$67.00BASV
2$11,539$43.45$11,407$389.39+$132.00BASV
3$12,390$43.62$12,198$426.53+$192.00BASV
4$13,301$43.77$13,056$467.62+$245.00BASV
5$14,276$43.92$13,987$513.12+$289.00BASV
6$15,320$44.05$14,998$563.56+$322.00BASV
7$16,436$44.18$16,098$619.52+$338.00BASV
8$17,631$44.30$17,295$681.69+$336.00BASV
9$18,909$44.41$18,599$750.82+$310.00BASV
10$20,278$44.51$20,022$827.78+$256.00BASV

BASV vs JNJ: Complete Analysis 2026

BASVStock

BASV invests in US large-cap companies using a proprietary approach that combines traditional valuation metrics with sustainability analysis. Stock selection targets those who generate stable free cash flow, exhibit strong financials, and trade at a discount to their intrinsic value. Key factors include earnings, cash flows, book value, sales, and growth relative to the companys history, industry, or the broader market. At the same time, integrating sustainability via the Sustainable Cash Flow Advantage (SCFA) framework, focusing on firms with strong practices in workforce management, operational efficiency, and products that drive environmental or social benefits. The fund typically holds 30 to 50 issuers. Up to 20% of the assets may be allocated to foreign securities, including emerging markets. Investments include common and preferred stocks, ADRs, REITs, convertibles, ETFs, BDCs, and private placements. The fund may hold undervalued cyclical companies.

Full BASV Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BASV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BASV vs SCHDBASV vs JEPIBASV vs OBASV vs KOBASV vs MAINBASV vs ABBVBASV vs MRKBASV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.